This session features speakers who will summarize up to date knowledge and future direction for research related to biological, physiological and social impacts of e-cigarette use, with particular focus on new users. Topics will include an overview of policy strengths and limitations related to regulation of e-cigarette and e-cigarette juice availability. Specific insight on molecular and cellular responses in the lung will be featured, including tissue remodeling, immunity and inflammation. A recent ATS workshop summary on EVALI will be featured, and the evolution of e-cigarette devices in the last decade will be discussed.
• Learn new findings about the biological and physiological impacts of e-cigarette and vaping use on the lung
• Improve understanding of the epidemiology, pathogenesis and clinical management of E-cigarette or vaping product use-associated lung injury (EVALI)
• Learn about existing and needed effective policies for the regulation of e-cigarette and vaping product availability
Alexandra Noel, PhD, MSc, BSc
Laura Crotty Alexander, MD, ATSF
Laura Crotty Alexander, MD, ATSF
Christopher Pascoe, PhD
Christopher Pascoe, PhD
Ilona Jaspers, PhD
Mario Perez, ATSF, MD, MPH
Inhaling- Vaping Updates from Animal and Human Studies
Results from the ATS EVALI Workshop Report - Critical Needs to Prevent Future Outbreaks of Vaping Induced Illness
E-cigarettes: Mice, Humans, and Policy, Oh My!
Questions and Answers
E-cigarette Use and Early Transcriptomic Alterations in Human Lung Tissue
Questions and Answers
Vaping Old and New and how it Alters Your Respiratory Immune Responses
Exhaling - Closing Remarks, What's next?